Evidence map›Paper›PMID 16854201›Full record

ArticleThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association2006

Evaluation of potential modifiers of the palatal phenotype in the 22q11.2 deletion syndrome.

Deborah A Driscoll, Torrey Boland, Beverly S Emanuel, Richard E Kirschner, Don LaRossa, Jeanne Manson, Donna McDonald-McGinn, Peter Randall, Cynthia Solot, Elaine Zackai and 1 more

Abstract read
In one paragraph

Article in The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Elevated homocysteine andOxford medical case reports · 2017
    Article
  4. Article
  5. Article
  6. Biallelic expression of Tbx1 protects the embryo from developmental defects caused by increased receptor tyrosine kinase signaling.Developmental dynamics : an official publication of the American Association of Anatomists · 2012
    Article
  7. Article
  8. Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome.Birth defects research. Part A, Clinical and molecular teratology · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Deborah A DriscollDepartment of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, USA.
Torrey Boland
Beverly S Emanuel
Richard E Kirschner
Don LaRossa
Jeanne Manson
Donna McDonald-McGinn
Peter Randall
Cynthia Solot
Elaine Zackai
Laura E Mitchell

Funding

TRANSGENIC MOUSE MODELS OF MENTAL RETARDATIONP30HD026979 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBERTS, TIMOTHY P · 1990 to 2015
$15.3M
VELOCARDIOFACIAL SYNDROME--MOLECULAR &CLINICAL STUDIESP01DC002027 · NIDCD · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI EMANUEL, BEVERLY S · 1994 to 2003
$6.4M
NICHD NIH HHS HD26979NICHD NIH HHS P30 HD026979NIDCD NIH HHS DC02027NIDCD NIH HHS P01 DC002027
6 · The paper itself

Abstract

objectiveTo evaluate potential modifiers of the palatal phenotype in individuals with the 22q11.2 deletion syndrome.

designData from 356 subjects enrolled in a study of the 22q11.2 deletion syndrome were used to evaluate potential modifiers of the palatal phenotype. Specifically, subjects with and without velopharyngeal inadequacy and/or structural malformations of the palate were compared with respect to gender, race, and genotype for variants of seven genes that may influence palatal development.

methodsThe chi-square test or Fisher exact test was used to evaluate the association between palatal phenotype and each potential modifier. Odds ratios and their associated 95% confidence intervals were used to measure the magnitude of the association between palatal phenotype, subject gender and race, and each of the bi-allelic variants.

resultsThe palatal phenotype observed in individuals with the 22q11.2 deletion syndrome was significantly associated with both gender and race. In addition, there was tentative evidence that the palatal phenotype may be influenced by variation within the gene that encodes methionine synthase.

conclusionsVariation in the palatal phenotype observed between individuals with the 22q11.2 deletion syndrome may be related to personal characteristics such as gender and race as well as variation within genes that reside outside of the 22q11.2 region.

Indexed as

Chromosome Deletion5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseChildChi-Square DistributionChromosome DisordersChromosomes, Human, Pair 22Cleft PalateCystathionine beta-SynthaseEthnicityFemaleFerredoxin-NADP ReductaseHumansMaleMethylenetetrahydrofolate Reductase (NADPH2)Palate, HardPhenotype5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseCystathionine beta-SynthaseFerredoxin-NADP Reductasemethionine synthase reductaseMethylenetetrahydrofolate Reductase (NADPH2)

Identifiers

PMID16854201
PMCPMC2818507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.